The "Innovations in Digital and Targeted Treatment Platforms" report has been added to ResearchAndMarkets.com's offering.
This Genetic Technology TOE depicts new life sciences trends across digital targeted therapeutic platforms. Human genetics, antibody therapies, digital oncology platforms, among others, are profiled. The clinical trials scenario for FoundationOne Platform is along depicted.
Key Topics Covered:
1. Advancements in Digital and Targeted Treatment Platforms
- Fueling Digital Therapy Platforms
- Leveraging Human Genetics for Drug Target Discovery
- Enabling Affordable Antibody Therapies
- Merging Precision Oncology Platforms for Personalized Healthcare
2. Clinical Trial Analysis and Key Contacts
- Analysis of Completed/Ongoing Clinical Trials for Foundation - One Platform
- Key Contacts
For more information about this report visit https://www.researchandmarkets.com/research/jfz4kz/innovations_in?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20180919005708/en/
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Genomics
